← Back to Clinical Trials
Recruiting NCT05218460

NCT05218460 Evaluation of Methodological and Technical DEvelopmeNts to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam on Voluntary Subjects

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05218460
Status Recruiting
Phase —
Sponsor Central Hospital, Nancy, France
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 720 participants
Start Date 2022-05-23
Primary Completion 2027-05-23

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
All Conditions
Interventions
MRI examination

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 720 participants in total. It began in 2022-05-23 with a primary completion date of 2027-05-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The EDEN study will make it possible to evaluate one or more development phases (from design to validation through optimization) of a method or a technique on voluntary subjects, in normal or pathological condition.

Eligibility Criteria

Inclusion Criteria for all subjects : * to be over 18 year-old, * to be enrolled in a social security plan, * to have underwent a pre-inclusion medical examination, * to give a written consent. Inclusion Criteria for volunteers with pathology : \- person with a pathology characterized by a functional and / or morphological alteration that may have an impact on the data collected (images, physiological signals, ...). Exclusion Criteria for all subjects : * any contraindication to MR examination (active medical device, ferromagnetic foreign body, pregnancy, morbid obesity, claustrophobia, … ), * subject under a measure of legal protection, * Person who refuses to be informed by a doctor in th event of a fortuitus discovery of an abnormality on the MRI examination requiring additionnal examinations or specific treatment.

Contact & Investigator

Central Contact

Damien MANDRY, MD, PhD

✉ d.mandry@chru-nancy.fr

📞 +33383154202

Frequently Asked Questions

Who can join the NCT05218460 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05218460 currently recruiting?

Yes, NCT05218460 is actively recruiting participants. Contact the research team at d.mandry@chru-nancy.fr for enrollment information.

Where is the NCT05218460 trial being conducted?

This trial is being conducted at Nancy, France.

Who is sponsoring the NCT05218460 clinical trial?

NCT05218460 is sponsored by Central Hospital, Nancy, France. The trial plans to enroll 720 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology